Neurol. praxi. 2016;17(6):366-369 | DOI: 10.36290/neu.2016.077
TDP43-proteinopathy in ALS: cognitive deficits in ALS, ALS Plus syndromes
- Neurologická klinika 2. LF UK a FN Motol, Praha
New insights into the molecular genetics and cellular pathophysiology of the amyotrophic lateral sclerosis changed the landscape of neurodegenerative diseases during the last two decades. The model of TDP-43 proteinopathy disseminating through the CNS along predetermined pathways brought an plausible explanation for seemingly unrelated symptoms. Hexanucleotid expansion of the gene C9ORF72, among other mutations, is an outstanding example of various manifestations of one genotype into different phenotypes, namingly FTD, ALS or combination of both disorders in one patient. Both former entities are now considered a part of a clinico-pathological spectrum of syndromes. This allows a preciser definition of the different subtypes of ALS with different prognosis. User-friendly tools for diagnostics and prognostication have been developed and could soon find its way to daily clinical routine.
Keywords: amyotrophic lateral sclerosis, frontotemporal dementia, TDP-43 proteinopathy
Published: December 1, 2016 Show citation
References
- Abrahams S, Newton J, Niven E. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar; 15(1-2): 9-14.
Go to original source... 
Go to PubMed... - Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front. Cell. Neurosci. 2015; 9: 423. Go to original source... Go to PubMed...
- Barulli MR, Fontana A, Panza F. Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open. 2015 Sep 3; 5(9): e007069. Go to original source... Go to PubMed...
- Brooks BR, Miller G, Swash M. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. ALS and other motor neuron disor. 2000; 1: 293-299. Go to original source... Go to PubMed...
- Braak H, Brettschneider J, Ludolph AC. Amyotrophic lateral sclerosis - a model of corticofugal axonal spread. Nat Rev Neurol. 2013 December; 9(12): 708-714. Go to original source... Go to PubMed...
- Burrell JR, Kiernan MC, Vucic S. Motor Neuron dysfunction in frontotemporal dementia. Brain 2011; 134: 2582-2594. Go to original source... Go to PubMed...
- Byrne S, Elamin M, Bede P. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012 Mar; 11(3): 232-240. Go to original source... Go to PubMed...
- Elamin M, Bede P, Byrne S. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology. 2013 Apr 23; 80(17): 1590-1597. Go to original source... Go to PubMed...
- Elamin M, Bede P, Montuschi A. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm.J Neurol. 2015 Jun; 262(6): 1447-54 Go to original source... Go to PubMed...
- Geser F, Brandmeir NJ, Kwong LK. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.Arch Neurol.2008 May; 65(5): 636-641. Go to original source... Go to PubMed...
- Geser F, Martinez-Lage M, Robinson J. Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies. Arch Neurol. 2009 February; 66(2): 180-189. Go to original source... Go to PubMed...
- Gorges M, Müller HP, Lulé D. Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis PLoS ONE 10(11) 6 e0142546. doi:10.1371/journal.pone.0142546. Go to original source...
- Harms MB Baloh RH. Clinical neurogenetics: Amyotrophic lateral sclerosis. Neurol Clin. 2013 Nov; 31(4): 929-950. Go to original source... Go to PubMed...
- Janssens J, Van Broeckhoven C. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet. 2013 Oct 15; 22(R1): R77-87. Go to original source... Go to PubMed...
- Jovicic A, Gitler AD. TDP-43 in ALS: Stay on Target...Almost There. Neuron 2014 Feb 5; 81(3): 463-465. Go to original source... Go to PubMed...
- Kanouchi T, Okhubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosurg Psychiatry 2012; 83: 739-745. Go to original source... Go to PubMed...
- Maková T. Validizační studie Frontal Assessment Battery k diagnostice dysexekutivního deficitu u Parkinsonovy nemoci. (Diplomová práce) is.muni.cz > Závěrečné práce.
- Majounie E, Renton AE, Mok K. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012 Apr; 11(4): 323-330. Go to original source... Go to PubMed...
- McCluskey L, Vandriel S, Elman L. ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci. 2014 October 15; 345(0): 118-124. Go to original source... Go to PubMed...
- Nonaka T, Masuda-Suzukake M, Arai T. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013 Jul 11; 4(1): 124-134. Go to original source... Go to PubMed...
- Oh SI, Park A, Kim HJ. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS One. 2014 Feb 3; 9(2): e87163 Go to original source... Go to PubMed...
- Osborne AR, Sekhon R, Johnston W. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014 Jan 15; 336(1-2): 191-196. Go to original source... Go to PubMed...
- Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013 Apr; 14(4): 248-264. Go to original source... Go to PubMed...